These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28478612)

  • 21. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factor polymorphisms and colorectal cancer risk.
    Morimoto LM; Newcomb PA; White E; Bigler J; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1204-11. PubMed ID: 15894673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post genome-wide gene-environment interaction study: The effect of genetically driven insulin resistance on breast cancer risk using Mendelian randomization.
    Jung SY; Mancuso N; Papp J; Sobel E; Zhang ZF
    PLoS One; 2019; 14(6):e0218917. PubMed ID: 31246991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic and environmental predictors, endogenous hormones and growth factors, and risk of estrogen receptor-positive breast cancer in Japanese women.
    Yoshimoto N; Nishiyama T; Toyama T; Takahashi S; Shiraki N; Sugiura H; Endo Y; Iwasa M; Fujii Y; Yamashita H
    Cancer Sci; 2011 Nov; 102(11):2065-72. PubMed ID: 21790896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women's Health Initiative.
    Pan K; Chlebowski RT; Mortimer JE; Gunter MJ; Rohan T; Vitolins MZ; Adams-Campbell LL; Ho GYF; Cheng TD; Nelson RA
    Cancer; 2020 Aug; 126(16):3638-3647. PubMed ID: 32530506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: personal and lifestyle factors (United States).
    Morimoto LM; Newcomb PA; White E; Bigler J; Potter JD
    Cancer Causes Control; 2005 Oct; 16(8):917-27. PubMed ID: 16132801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial.
    Fairey AS; Courneya KS; Field CJ; Bell GJ; Jones LW; Mackey JR
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):721-7. PubMed ID: 12917202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-like growth factor 1 gene polymorphism in women with breast cancer.
    Costa-Silva DR; da Conceição Barros-Oliveira M; Borges RS; Campos-Verdes LM; da Silva-Sampaio JP; Escorcio-Dourado CS; Martins LM; Alencar AP; Baracat EC; Silva VC; da Silva BB
    Med Oncol; 2017 Apr; 34(4):59. PubMed ID: 28315227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study.
    Deming SL; Ren Z; Wen W; Shu XO; Cai Q; Gao YT; Zheng W
    Breast Cancer Res Treat; 2007 Sep; 104(3):309-19. PubMed ID: 17063263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
    Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.
    Rivadeneira F; van Meurs JB; Kant J; Zillikens MC; Stolk L; Beck TJ; Arp P; Schuit SC; Hofman A; Houwing-Duistermaat JJ; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
    J Bone Miner Res; 2006 Sep; 21(9):1443-56. PubMed ID: 16939403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post Genome-Wide Gene-Environment Interaction Study Using Random Survival Forest: Insulin Resistance, Lifestyle Factors, and Colorectal Cancer Risk.
    Jung SY; Papp JC; Sobel EM; Zhang ZF
    Cancer Prev Res (Phila); 2019 Dec; 12(12):877-890. PubMed ID: 31554631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project.
    Cleveland RJ; Gammon MD; Edmiston SN; Teitelbaum SL; Britton JA; Terry MB; Eng SM; Neugut AI; Santella RM; Conway K
    Carcinogenesis; 2006 Apr; 27(4):758-65. PubMed ID: 16332723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms in the IGF-1 and IGFBP 3 promoter and the risk of breast cancer.
    Wagner K; Hemminki K; Israelsson E; Grzybowska E; Söderberg M; Pamula J; Pekala W; Zientek H; Mielzynska D; Siwinska E; Försti A
    Breast Cancer Res Treat; 2005 Jul; 92(2):133-40. PubMed ID: 15986122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The GH1/IGF-1 axis polymorphisms and their impact on breast cancer development.
    Wagner K; Hemminki K; Försti A
    Breast Cancer Res Treat; 2007 Sep; 104(3):233-48. PubMed ID: 17082888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Common genetic variation in the IGF-1 gene, serum IGF-I levels and breast density.
    Verheus M; McKay JD; Kaaks R; Canzian F; Biessy C; Johansson M; Grobbee DE; Peeters PH; van Gils CH
    Breast Cancer Res Treat; 2008 Nov; 112(1):109-22. PubMed ID: 18064566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variants of LEAP2 are associated with anthropometric traits and circulating insulin-like growth factor-1 concentration: A UK Biobank study.
    Andreoli MF; Gentreau M; Rukh G; Perello M; Schiöth HB
    Diabetes Obes Metab; 2024 Sep; 26(9):3565-3575. PubMed ID: 38888057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioavailable insulin-like growth factor-I inversely related to weight gain in postmenopausal women regardless of exogenous estrogen.
    Jung SY; Hursting SD; Guindani M; Vitolins MZ; Paskett E; Chang S
    Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):534-44. PubMed ID: 24363252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer susceptibility variants and mammographic density phenotypes in norwegian postmenopausal women.
    Ellingjord-Dale M; Grotmol T; Lee E; Van Den Berg DJ; Hofvind S; Couto E; Sovio U; Dos-Santos-Silva I; Ursin G
    Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1752-63. PubMed ID: 25002657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
    Davis SR; Stuckey BG; Norman RJ; Papalia MA; Drillich A; Bell RJ
    Menopause; 2008; 15(6):1065-9. PubMed ID: 18806686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.